Screening procedure for β-adrenergic drugs in sports drug testing by immunological methods

Journal of Analytical Toxicology

Volumn 22, Issue 2, 1998, Pages 127-134

  Ventura, R ^a   Gonzalez G ^a   Smeyers, M T ^a   De La Torre, R ^a   Segura, J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYPROPRANOLOL; ACEBUTOLOL; ALPRENOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BISOPROLOL; CARTEOLOL; CLENBUTEROL; LABETALOL; LEVOBUNOLOL; MEPINDOLOL; METOPROLOL; NADOLOL; ORCIPRENALINE; OXPRENOLOL; PENBUTOLOL; PINDOLOL; PRACTOLOL; PROPRANOLOL; SALBUTAMOL; SOTALOL; TERBUTALINE; TIMOLOL;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS REACTION; DOPING; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MASS SPECTROMETRY; NORMAL HUMAN; STANDARD; URINARY EXCRETION; VALIDATION PROCESS;

EID: 0031885385     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/22.2.127     Document Type: Article

References (14)

1. International Olympic Committee. Prohibited classes of substances and prohibited methods. In IOC Medical Code and Explanatory Document. IOC, Lausanne, Switzerland, 1995.
2. B.B. Hoffman and R.J. Lefkowitz. Adrenergic receptor antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. A. Goodman Gilman, T.W. Rall, A.S. Nies, and P. Taylor, Eds. Pergamon Press, New York, NY, 1990, pp 221-243.
3. R.C. Baselt and R.H. Cravey. Disposition of Toxic Drugs and Chemicals in Man, 4th ed. Chemical Toxicology Institute, Foster City, CA, 1995.
4. D.J. Morgan. Clinical pharmacokinetics of β-agonists. Clin. Pharmacokinet. 18(4): 270-294 (1990).
5. M.S. Leloux, E.G. De Jong, and R.A.A. Maes. Improved screening method for beta-blockers in urine using solid-phase extraction and capillary gas chromatography-mass spectrometry. J. Chromatogr. 488: 357-367 (1989).
6. J. Zamecnik. Use of cyclic boronates for GC/MS screening and quantitation of beta-adrenergic blockers and some bronchodilators. J. Anal. Toxicol. 14: 132-136 (1990).
7. D.-S. Lho, J.-K. Hong, H.-K. Paek, J.-A. Lee, and J. Park. Determination of phenolalkylamines, narcotic analgesics, and beta-blockers by gas chromatography/mass spectrometry. J. Anal. Toxicol. 14: 77-83 (1990).
8. M.C. Dumasia and E. Houghton. Screening and confirmatory analysis of β-agonists, β-antagonists and their metabolites in horse urine by capillary gas chromatography-mass spectrometry. J. Chromatogr. Biomed. Appl. 564: 503-513 (1991).
9. A. Solans, M. Carnicero, R. de la Torre, and J. Segura. Comprehensive screening procedure for detection of stimulants, narcotics, adrenergic drugs, and their metabolites in human urine. J. Anal. Toxicol. 19: 104-114 (1995).
10. A. Polettini, A. Groppi, M.C. Ricossa, and M. Montagna. Gas chromatographic/electron impact mass spectrometric selective confirmatory analysis of clenbuterol in human and bovine urine. Biol. Mass Spectrom. 22: 457-461 (1993).
11. IOC Statistics 1994, International Olympic Committee, internal communication, 1995.
12. C.A. Golden. Overview of the state of the art of immunoassay screening tests. J. Am. Vet. Med. Assoc. 198(5): 827-830 (1991).
13. J. Segura, R. de la Torre, M. Donike, J. Aubets, M. Mestres, and J. Camí. Value of enzyme immunoassay in the dope control of phenylalkylamines. Proceedings III World Conference Clinical Pharmacology. Stockholm, Sweden, 1986, p 121.
14. R. de la Torre, R. Badia, G. González, M. García, M.J. Pretel, M. Farré, and J. Segura. Cross-reactivity of stimulants found in sports drug testing by two fluorescence polarization immunoassays. J. Anal. Toxicol. 20: 165-170 (1996).